Section 5: Preservation of embryos and embryonic stem cells for research purposes.

Subject to the provisions of the second paragraph of Article L. 2151-9, the Director General of the Biomedicine Agency shall authorise the storage of embryos, after obtaining the opinion of the Steering Committee, for a fixed period, which may not exceed five years, renewable under the same conditions. The authorisation shall state the name of the person responsible for the storage activity. Prior to the Director General’s decision, the Agence…

The provisions of articles R. 2151-6 and R. 2151-8 to R. 2151-12 apply to the authorisations provided for in this section.

When suspending or withdrawing an authorisation to store embryos, the Director General of the Agence de la biomédecine organises the transfer of these embryos to another organisation authorised to store them in execution, where applicable, of the agreement referred to in Article R. 2151-19. In the event of an incident likely to affect health safety, the Director General of the Agence de la biomédecine shall immediately inform the Director General…